Mueller T C, Johansson L, Schröder R. "一种的合成方法" [P]. European Patent, EP 3398362 A1, 2019-11-13.
Chen K W, Yamamoto T, O'Brien P Q. "Method for the Synthesis of 5-(1-Methylcyclopropyl)-1,3,4-oxadiazol-2(3H)-one" [P]. US Patent, US 10438259 B2, 2024-02-15.
Johansson L, Jørgensen K, Rossi M. "A Process for Preparing High-Purity 5-(1-Methylcyclopropyl)-1,3,4-oxadiazol-2(3H)-one" [P]. European Patent, EP 3290596 A1, 2020-07-13.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2011, 730, 7482-7503.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2016, 503, 6571-6600.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 5-(1-Methylcyclopropyl)-1,3,4-oxadiazol-2(3H)-one Using HRMS and NMR". Phytochemistry, 2011, 1247, (10), 8160-8189.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2024, 2024, 4483-4502.